What are the side effects of trazodone in elderly patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Trazodone Side Effects in Elderly Patients

Trazodone poses significant risks in elderly patients, particularly orthostatic hypotension leading to falls and syncope, sedation with cognitive impairment, and hyponatremia—these adverse effects occur frequently enough that alternative agents should be strongly considered for most geriatric indications.

Primary Safety Concerns

Falls and Orthostatic Hypotension (Most Critical)

The most concerning adverse effect in elderly patients is orthostatic hypotension with subsequent falls and syncope. Recent evidence demonstrates that elderly hypertensive patients on trazodone experience:

  • Significantly greater systolic BP drop immediately upon standing (23.8 vs 14.3 mmHg) 1
  • Greater diastolic BP drop both immediately (8.9 vs 1.6 mmHg) and at 1 minute (6.5 vs 0 mmHg) 1
  • 58.3% incidence of syncope and falls compared to 21.2% in non-users 1
  • Falls were the most frequent adverse event in long-term care facilities, affecting 30% of users 2

This orthostatic effect is dose-independent and occurs even at low doses commonly used for insomnia.

Sedation and Cognitive Impairment

Trazodone causes significant sedation that impairs mental and physical abilities required for potentially hazardous tasks 3. In elderly patients, this manifests as:

  • Drowsiness/sedation with increased fall risk 4
  • Psychomotor impairment 5
  • Potential cognitive slowing

The FDA label explicitly warns that trazodone may impair performance and cautions against operating machinery until effects are known 3.

Hyponatremia

Elderly patients are at particularly high risk for clinically significant hyponatremia 3. This risk is amplified in patients taking diuretics or who are volume-depleted 3. Symptoms include:

  • Headache, confusion, weakness
  • Memory impairment and unsteadiness leading to falls
  • Severe cases: hallucinations, syncope, seizures, coma 3

Cases with serum sodium <110 mmol/L have been reported, often due to SIADH 3.

Additional Significant Adverse Effects

Cardiac Effects

  • QTc prolongation: Dose-dependent moderate prolongation with risk of ventricular arrhythmias 4
  • Irregular or fast heartbeat 3
  • Particularly concerning in elderly patients with pre-existing cardiac conditions

Extrapyramidal Symptoms

Acute extrapyramidal events can occur even at low doses in elderly patients 6, contrary to the common perception that trazodone lacks these effects.

Other Common Side Effects

Per FDA labeling, the most common adverse effects include 3:

  • Swelling
  • Blurred vision and potential angle-closure glaucoma in susceptible patients 3
  • Dizziness
  • Tiredness
  • Diarrhea
  • Weight changes

Rare but Serious

  • Priapism: Men should discontinue immediately if erection lasts >4-6 hours 3
  • Serotonin syndrome: Risk increases with concomitant serotonergic medications 3
  • Withdrawal symptoms upon discontinuation: anxiety, agitation, sleep problems 3

Clinical Context and Tolerability

Despite these risks, real-world data shows trazodone is reported as partially or totally effective in >90% of elderly users in long-term care 2. However, high discontinuation rates due to adverse effects are documented, particularly sedation, dizziness, and psychomotor impairment 5.

The 2017 AASM guideline notably does not recommend trazodone for treating insomnia, showing minimal improvement in sleep parameters (10 min reduction in sleep latency, 8 min reduction in wake after sleep onset) with no improvement in subjective sleep quality 7.

Key Clinical Pitfalls

  1. Low-dose myth: Adverse effects, particularly orthostatic hypotension and falls, occur even at doses of 25-75 mg commonly prescribed for insomnia
  2. Polypharmacy interactions: Risk of serotonin syndrome with SSRIs, SNRIs, or other serotonergic agents; increased hyponatremia risk with diuretics
  3. Underestimating fall risk: The 58% rate of syncope/falls in elderly users is clinically unacceptable for most patients 1
  4. Cardiac screening: QTc should be monitored, especially at higher doses or in patients with cardiac history

Safer Alternatives

For elderly patients with depression, guidelines recommend citalopram, escitalopram, sertraline, mirtazapine, venlafaxine, or bupropion over trazodone, explicitly stating paroxetine and fluoxetine should be avoided due to higher adverse effect rates 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.